At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 80 enrolled
Drug / intervention
Placebo to BI 1026706 solution +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effectiveness and Safety of Different Doses of BI 1026706 in Patients With Postoperative Dental Pain (a Single-centre, Partially Double-blinded, Randomised, placebo-and Active Comparator-controlled, Single-dose, Parallel-group Study)
In Brief
A Phase 1 clinical trial evaluating Placebo to BI 1026706 solution, BI 1026706, and 2 other interventions for Pain, Postoperative. Completed, enrolled 80 participants across 1 site.
Detailed Summary
To investigate the effectiveness of BI 1026706 powder for reconstitution of an oral solution compared to placebo and the relative effectiveness compared to Celecoxib.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Postoperative
CountriesItaly
Collaborators--
Timeline
Phase 1CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartMar 2014
First PostedMar 2014
Primary CompletionOct 2014
TodayJul 2026
First PostedMar 12, 2014
Enrollment StartMar 1, 2014
Primary CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 12.3 years ago
Interventions
Placebo to BI 1026706 solutiondrug
Placebo to BI 1026706 solution
BI 1026706drug
BI 1026706
Placebo to BI 1026706 tabletdrug
Placebo to BI 1026706 tablet
Celecoxibdrug
Celecoxib capsule